EPA059 Effect of novel latency reversal agents on transposable element expression profile in T-cell memory subsets of HIV clinical samplesE-posterStrategies to reduce/eliminate viral reservoirs
EPA046 Effect of human immunodeficiency virus type 1 (HIV-1) subtype C transactivator of transcription (Tat) P21A variant on nuclear levels of active positive transcription elongation factor b (P-TEFb)E-posterHost cellular factors and viral mechanisms of HIV/SIV persistence and latency
PEMOE36 Effect of district ART access on young people's wellbeing in South Africa: an econometric analysis of panel dataPoster exhibitionMonitoring and reporting in the SDG era
EPD565 Effect of COVID-19 on risky behaviours of female sex workers in Ga South Municipal of Ghana and its wider implications: evidence from a qualitative studyE-posterEffects of the COVID-19 on key populations
EPC463 Effect of COVID-19 on HIV prevention among the LGBTQ+ population in New York City (NYC)E-posterEffects of the COVID-19 on HIV epidemiology and prevention
EPD170 Effect of community and facility-based care on viral load suppression among young women on ART in the Mulago Immune Suppression (ISS) clinicE-posterYoung key populations
PEMOC35 Effect of combination Needle and Syringe Program and Opioid Agonist Therapy on HIV and hepatitis C virus acquisition among people who inject drugs: a comparison between Amsterdam, Melbourne and VancouverPoster exhibitionAccess to harm reduction interventions
PEMOC39 Effect of client profiling for tailored adherence support on ART retention among children and adolescents living with HIV/AIDS in an OVC program in NigeriaPoster exhibitionMeasuring and enhancing retention and adherence in HIV prevention programmes
EPC130 Effect of cash transfer programs on HIV outcomes: a systematic review and meta-analysisE-posterMeasuring the population-level impact of policy-level HIV interventions
EPE093 Effect of a one-time financial incentive on linkage to chronic hypertension care in Kenya and Uganda: a randomized controlled trialE-posterScaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health)
1831 - 1840 of 2485 items